BioLargo Reports Annual 2025 Operating and Financial Results
Accessnewswire·2026-03-05 14:35
Core Insights - BioLargo, Inc. reported a cash balance of $3.9 million at the end of 2025, indicating a stable financial position as the company focuses on commercialization across several business segments [1] Financial Performance - The annual report covers the financial results for the year ended December 31, 2025, highlighting the company's disciplined execution in its operations [1] Business Development - BioLargo is engaged in creating and commercializing sustainable technologies aimed at addressing significant environmental and cleantech challenges, showcasing its commitment to innovation in these sectors [1]